Pregabalin in fibromyalgia - responder analysis from individual patient data
<p>Abstract</p> <p>Background</p> <p>Population mean changes are difficult to use in clinical practice. Responder analysis may be better, but needs validating for level of response and treatment duration. A consensus group has defined what constitutes minimal, moderate,...
Main Authors: | Paine Jocelyn, Moore R Andrew, Derry Sheena, Straube Sebastian, McQuay Henry J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-07-01
|
Series: | BMC Musculoskeletal Disorders |
Online Access: | http://www.biomedcentral.com/1471-2474/11/150 |
Similar Items
-
Pregabalin in fibromyalgia--responder analysis from individual patient data.
by: Straube, S, et al.
Published: (2010) -
Interference with work in fibromyalgia - effect of treatment with pregabalin and relation to pain response
by: Hallier Ernst, et al.
Published: (2011-06-01) -
Interference with work in fibromyalgia: effect of treatment with pregabalin and relation to pain response.
by: Straube, S, et al.
Published: (2011) -
Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports.
by: Straube, S, et al.
Published: (2010) -
Response to: Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: How study designs can affect placebo factors.
by: Moore, R, et al.
Published: (2008)